Aspen Pharmacare Holdings Limited (APNHY)
Aspen Pharmacare Holdings Limited operates in the Drug Manufacturers - Specialty & Generic industry of the Healthcare sector, headquartered in Durban, NL, ZA. The stock last traded at $10.15, up 0.50% on the session, giving a market capitalisation of $4.39B. On trailing twelve-month figures it carries a trailing P/E of 29.89, a net margin of 7.6%. Its beta of 0.40 implies it has historically moved less than the broad market.
Aspen Pharmacare Holdings Limited is a global pharmaceutical entity that develops, manufactures, and distributes a wide array of specialized and branded medicinal products. The company operates through two primary segments: Commercial Pharmaceuticals and Manufacturing. Its diverse product portfolio encompasses essential anesthetic agents, such as general anesthetics, muscle relaxants, and topical preparations. Aspen also provides a comprehensive suite of thrombosis treatments, including various injectable anticoagulants like low molecular weight heparins, Xa inhibitors, and other heparin derivatives. Beyond these, the firm markets numerous regional consumer, prescription, and over-the-counter brands, such as Circadin for sleep, Foxair for respiratory ailments, Maltofer as an iron supplement, Mybulen for pain management, and Zyloric for gout. Additionally, Aspen produces active pharmaceutical ingredients and finished dose form products for other companies. Established in 1850, the company's headquarters are located in Durban, South Africa.
Aspen Pharmacare Holdings Limited is most often compared with the following Healthcare names: